BIOMAT Database Logo BIOMAT Database Logo

Bleomycin is a potent small-molecule inhibitor of hepatitis C virus replication. 2006

Bojana Rakić, and Marc Brûlotte, and Yanouchka Rouleau, and Sylvie Bélanger, and John Paul Pezacki
The Steacie Institute for Molecular Sciences, National Research Council of Canada, 100 Sussex Drive, Ottawa, K1A 0R6, Canada.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D012093 Replicon Any DNA sequence capable of independent replication or a molecule that possesses a REPLICATION ORIGIN and which is therefore potentially capable of being replicated in a suitable cell. (Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Replication Unit,Replication Units,Replicons,Unit, Replication,Units, Replication
D001761 Bleomycin A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors. BLEO-cell,Blanoxan,Blenoxane,Bleolem,Bleomicina,Bleomycin A(2),Bleomycin A2,Bleomycin B(2),Bleomycin B2,Bleomycin Sulfate,Bleomycins,Bleomycinum Mack,Bléomycine Bellon,BLEO cell,BLEOcell,Bellon, Bléomycine,Mack, Bleomycinum,Sulfate, Bleomycin
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006888 Hydroxycholesterols Cholesterol which is substituted by a hydroxy group in any position.
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications

Related Publications

Bojana Rakić, and Marc Brûlotte, and Yanouchka Rouleau, and Sylvie Bélanger, and John Paul Pezacki
A small-molecule inhibitor of hepatitis C virus infectivity.
January 2014, Antimicrobial agents and chemotherapy,
Bojana Rakić, and Marc Brûlotte, and Yanouchka Rouleau, and Sylvie Bélanger, and John Paul Pezacki
Practical synthesis of a potent hepatitis C virus RNA replication inhibitor.
September 2004, The Journal of organic chemistry,
Bojana Rakić, and Marc Brûlotte, and Yanouchka Rouleau, and Sylvie Bélanger, and John Paul Pezacki
A novel small molecule inhibitor of hepatitis C virus entry.
September 2010, PLoS pathogens,
Bojana Rakić, and Marc Brûlotte, and Yanouchka Rouleau, and Sylvie Bélanger, and John Paul Pezacki
Identification of AP80978, a novel small-molecule inhibitor of hepatitis C virus replication that targets NS4B.
June 2014, Antimicrobial agents and chemotherapy,
Bojana Rakić, and Marc Brûlotte, and Yanouchka Rouleau, and Sylvie Bélanger, and John Paul Pezacki
Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors.
November 2011, Bioorganic & medicinal chemistry letters,
Bojana Rakić, and Marc Brûlotte, and Yanouchka Rouleau, and Sylvie Bélanger, and John Paul Pezacki
The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro.
April 2006, Hepatology (Baltimore, Md.),
Bojana Rakić, and Marc Brûlotte, and Yanouchka Rouleau, and Sylvie Bélanger, and John Paul Pezacki
Ceestatin, a novel small molecule inhibitor of hepatitis C virus replication, inhibits 3-hydroxy-3-methylglutaryl-coenzyme A synthase.
August 2011, The Journal of infectious diseases,
Bojana Rakić, and Marc Brûlotte, and Yanouchka Rouleau, and Sylvie Bélanger, and John Paul Pezacki
A small-molecule probe for hepatitis C virus replication that blocks protein folding.
October 2006, Chemistry & biology,
Bojana Rakić, and Marc Brûlotte, and Yanouchka Rouleau, and Sylvie Bélanger, and John Paul Pezacki
A novel small-molecule inhibitor of hepatitis C virus replication acts by suppressing signal transducer and activator of transcription 3.
July 2015, The Journal of antimicrobial chemotherapy,
Bojana Rakić, and Marc Brûlotte, and Yanouchka Rouleau, and Sylvie Bélanger, and John Paul Pezacki
A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties.
October 2004, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!